The efficacy of rituximab for children with refractory nephrotic syndrome

The efficacy of rituximab for children with refractory nephrotic syndrome - Rituximab for children with refractory nephrotic syndrome

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009411

Enrollment

Registered

2012-12-01

Start date

2013-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

steroid dependent nephrotic synrdome and frequent relapsing nephrotic syndrome

Interventions

administration of rituximab

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: steroid dependent and/or frequent relapsing nephrotic syndrome regardless of every health insurance treatment

Exclusion criteria

Exclusion criteria: steroid resistant nephrotic syndrome

Design outcomes

Primary

Measure	Time frame
the duration of remission	—

Countries

Japan

Contacts

Public ContactHiroshi Kaito

Kobe University Graduate School of Medicine Department of Pediatrics

rinri@med.kobe-u.ac.jp078-382-6090

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026